MariMed Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

NOTE 12 - LOSS ON EXTINGUISHMENT OF DEBT

NOTE 12 - LOSS ON EXTINGUISHMENT OF DEBT	12 Months Ended
Dec. 31, 2014
Debt Disclosure [Abstract]
NOTE 12 - LOSS ON EXTINGUISHMENT OF DEBT	NOTE 12 - LOSS ON EXTINGUISHMENT OF DEBT During the nine months ended December 31, 2014, the Company issued 129,688 shares of common stock with a $29,828 fair market value to pay off the accrued expense in amount of $10,750. The $19,078 difference between the fair market value of the common stock and the balance of accrued expense was booked as loss on extinguishment of debt.

NOTE 12 - LOSS ON EXTINGUISHMENT OF DEBT

12 Months Ended

Dec. 31, 2014

NOTE 12 - LOSS ON EXTINGUISHMENT OF DEBT

NOTE 12 - LOSS ON EXTINGUISHMENT OF DEBT

During the nine months ended December 31, 2014, the Company issued 129,688 shares of common stock with a $29,828 fair market value to pay off the accrued expense in amount of $10,750. The $19,078 difference between the fair market value of the common stock and the balance of accrued expense was booked as loss on extinguishment of debt.